GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (HKSE:00013) » Definitions » Sale Of Business

HUTCHMED (China) (HKSE:00013) Sale Of Business : HK$0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is HUTCHMED (China) Sale Of Business?

HUTCHMED (China)'s sale of business for the six months ended in Jun. 2024 was HK$0 Mil. It means HUTCHMED (China) gained HK$0 Mil from selling business. HUTCHMED (China)'s sale of business for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0 Mil.

Compared with last quarter (HK$0 Mil in Dec. 2023 ), HUTCHMED (China) gained the same money from selling business in Jun. 2024 (HK$0 Mil).


HUTCHMED (China) Sale Of Business Historical Data

The historical data trend for HUTCHMED (China)'s Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HUTCHMED (China) Sale Of Business Chart

HUTCHMED (China) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only 130.87 - - 2.52 39.85

HUTCHMED (China) Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

HUTCHMED (China) Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HUTCHMED (China) Sale Of Business Related Terms

Thank you for viewing the detailed overview of HUTCHMED (China)'s Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


HUTCHMED (China) Business Description

Address
2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
Executives
Deutsche Bank Aktiengesellschaft 2303 Depositary
M&g Plc 2201 Interest of corporation controlled by you
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you
The Goldman Sachs Group, Inc. 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.
Ck Hutchison Holdings Limited 2201 Interest of corporation controlled by you
Ck Hutchison Global Investments Limited
Hutchison Whampoa (china) Limited
Hutchison Healthcare Holdings Limited

HUTCHMED (China) Headlines

No Headlines